All News

Copay Assistance Programs Help Patients but Confuse Them Too

d MedPage Today

"If you're having trouble paying for your medications, Drug Company X may be able to help."

Read Article
podcast logo

RheumNow Podcast – Steroids, IVIG & the Vaccine (1.15.2021)

d Jack Cush, MD

Dr. Jack Cush reviews the news and journal reports from the past week on RheumNow.com. How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more...

Read Article
2020 Year Review

2020 Rheumatology Year in Review

d Jack Cush, MD

2020 was historic, memorable and game-changing. Under the cloud of COVID-19, there were many significant and memorable advances and setbacks for the rheumatology world. In our accounting of most read articles for 2020, (not surprisingly) 17/20 were COVID-related.

Read Article
New QD Clinic—This week’s videos: Clinic Emergencies, Stopping Meds, 3 Issues After COVID Vaccination, My New Clinic COVID Routine, Raynaud's or Not https://t.co/R0zcRq6Sg1

Links:

Dr. John Cush RheumNow ( View Tweet)

Copay Assistance Programs Help Patients but Confuse Them Too https://t.co/WuPkwrE3ZF

Links:

Dr. John Cush RheumNow ( View Tweet)

Type I interferon (IFN1) produced by plasmacytoid dendritic cells are prime drivers of adaptive immunity. Study of 137 SLE pts shows that baseline IFN1 scores correl w/ Dz activity, # flares, prednisone doses, immunosuppressive use over 5 yrs https://t.co/OGb4NfrcIU

Links:

Dr. John Cush RheumNow ( View Tweet)

RheumNow Podcast Now UP – Steroids, IVIG & the Vaccine. How to handle COVID19 Vaccine issues, IL-6 inhibition in COVID, Comorbidites in RA, IVIG in dermatomyositis, & more... https://t.co/f0wWTm2kV5

Links:

Dr. John Cush RheumNow ( View Tweet)

New Download Available on COVID-19 & mRNA Vaccines https://t.co/mvmn17Fl3B https://t.co/ceICzbDZi5

Links:

Dr. John Cush RheumNow ( View Tweet)
QD Clinic - What to do After COVID Vaccination https://t.co/25RcMOdAkK https://t.co/EWnYJGNqvY

Links:

Dr. John Cush RheumNow ( View Tweet)
2020 Rheumatology Year in Review-- Read our top news items that rheumatologists should recollect and integrate into clinical standards for 2021 and beyond. https://t.co/QisCpdcLEa https://t.co/pZekUvcomE

Links:

Dr. John Cush RheumNow ( View Tweet)
Rheumatologists: Record your question or case for the RheumNow podcast. https://t.co/wzNmOzH4VE https://t.co/dgTTvRqESI

Links:

Dr. John Cush RheumNow ( View Tweet)
ProDERM Study: IVIG in Dermatomyositis--The ProDERM study show that IVIg is safe, effective and superior to placebo in patients with dermatomyositis (DM). https://t.co/HOB8CYn9yc https://t.co/AmT3AQdawa

Links:

Dr. John Cush RheumNow ( View Tweet)
Real good historic review of RA drug development wherein Dr Paul Emery interviews Dr. Mike Weinblatt - Good Listen from the Cytokine Signaling Forum podcast https://t.co/R7rg7AwVlG

Links:

Dr. John Cush RheumNow ( View Tweet)

QD Clinic - Stopping Meds https://t.co/zhtAHLeGqT https://t.co/rFmCch4WJ4

Links:

Dr. John Cush RheumNow ( View Tweet)
ACR Convergence 2020 Fireside Chats – top presentations in Still’s disease Sponsored by Novartis Medical Affairs Unable to attend all the key sessions at ACR Convergence 2020? Listen to the experts as they present their views on the top abstracts. https://t.co/MD6lU5oIvy

Links:

Dr. John Cush RheumNow ( View Tweet)

Long Term Safety and Efficacy of Tacrolimus in Lupus Nephritis--Takeuchi et al has published their extensive experience with long-term tacrolimus use in lupus nephritis patients showing its real-world safety and efficacy. https://t.co/hgMp5GcyFA https://t.co/Xdxg3v3wMm

Links:

Dr. John Cush RheumNow ( View Tweet)
Good reference Medical Research Council Manual Muscle scale (0-5) 0 No muscle activation 1 Trace muscle movt/twitch 2 Muscle movt w/o gravity 3 Movt against gravity 4 Movt against some resistance 5 Movt against full resistance, full range of motion https://t.co/UVN6oHIL1L

Links:

Dr. John Cush RheumNow ( View Tweet)

Delays in Diagnosis of Axial Spondyloarthritis-Researchers found tht from 64 included studiesl, the mean diagnostic delay in axSpA patients was 6.7 years (95% CI 6.2, 7.2) with high levels of heterogeneity. https://t.co/cOC1R264aC https://t.co/5UC7aip7j0

Links:

Dr. John Cush RheumNow ( View Tweet)
Hydroxychloroquine Shortage During COVID-19--According to a recent report in Annals of Rheumatic Disease, public enthusiasm for hydroxychloroquine (HCQ) created significant access issues for rheumatic patients in the early phases of the COVID-19 pandemic. https://t.co/h9hrAfv9xo https://t.co/IVSYCueK2h

Links:

Dr. John Cush RheumNow ( View Tweet)
2 yr Early RA cohort (CareRA) study found that RA pPatients with co-morbidities had over time lower chances of achieving remission (OR = 0.724; 95% CI: 0.604, 0.867) and a higher risk of hospitalization (OR = 3.725; 95% CI: 2.136, 6.494).https://t.co/B1um1iMSKu

Links:

Dr. John Cush RheumNow ( View Tweet)

×